3-iodobenzylguanidine has been researched along with Cardiac Death in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T; Maruyama, K; Nakajima, K; Nakata, T; Tada, H | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
| Jacobson, AF; Kasama, S; Matsui, T; Matsuo, S; Momose, M; Nakajima, K; Nakata, T; Travin, MI; Yamada, T; Yamashina, S | 1 |
| Fukuyama, T; Imamura, Y; Miyagawa, M; Mochizuki, T; Watanabe, K | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Cardiac Death
| Article | Year |
|---|---|
Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiomyopathies; Death; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
3 other study(ies) available for 3-iodobenzylguanidine and Cardiac Death
| Article | Year |
|---|---|
Machine learning-based risk model using
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Death; Heart Failure; Humans; Iodine Radioisotopes; Machine Learning; Middle Aged; Stroke Volume; Ventricular Function, Left | 2022 |
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging.
Topics: 3-Iodobenzylguanidine; Analysis of Variance; Chronic Disease; Death; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Radionuclide Imaging; Risk | 2014 |